Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients.
about
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Do we have clarity on the therapeutic levels of morphine and its metabolites: seeking answers for the dilemma?The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation.Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients
P2860
Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@en
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@nl
type
label
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@en
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@nl
prefLabel
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@en
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@nl
P356
P1476
Pharmacogenetic vs. concentrat ...... in renal allograft recipients.
@en
P2093
D R J Kuypers
P2888
P304
595-6; author reply 597
P356
10.1038/CLPT.2010.129
P407
P577
2010-07-21T00:00:00Z
P6179
1039816308